Page 28 - Preventive Screening News Today

Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say.

The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost-effectively identify those at risk who could potentially receive it.

An analysis from Italy shows that during the second year of the pandemic, colorectal cancer (CRC) was diagnosed at more advanced stages, prompting concerns that this will translate to a dip in survival.

A newly discovered genetic variant that is associated with type 2 diabetes is responsible for almost 7% of all diabetes cases in Greenland, according to a whole-genome sequencing analysis of 448 Greenlandic Inuit individuals.

A newly developed risk score may help clinicians determine an individuals probability of dementia over 5, 9, and 13 years, allowing for more time to potentially intervene.

Mixed results from a quality improvement project to educate multidisciplinary providers on the value of primary care screening for sexually transmitted infections.

The 2023 Medicare Physician Fee Schedule includes some policy wins for gastroenterology while also finalizing expected pay-reduction provisions. ACG and AGA are among the groups fighting these cuts.

Teplizumab delayed progression to clinical type 1 diabetes by about 2 years compared with placebo in individuals destined to develop the condition because of autoantibody levels.

A novel risk prediction model suggests that women at low risk for breast cancer could soon be offered breast screening only once every few years.

Allowing young patients to return to TikTok may be better than screen-time bans for managing pediatric concussion.